Company Badge
USPTO Data Jan 1 1976 - Dec 2 2025
52 Patents
#40 in Cambridge, MA
#374 in Massachusetts
#6,532 in US
#13,135 in the World
Merrimack Pharmaceuticals, Inc.
Forward Citations = 444
81 inventors:
Cambridge, MA, United States of America
Merrimack Pharmaceuticals, Inc.
Patents = 52
Trademarks = 4
Forward Citations = 444
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
81 inventors (with patents filed for the assignee):
Ulrik Bjerl Nielsen (17 out of 24 patents)
Birgit Schoeberl (11 out of 16 patents)
Michael Feldhaus (10 out of 29 patents)
4. Neeraj Kohli (10 out of 12 patents)
5. Alexey Alexandrovich Lugovskoy (9 out of 50 patents)
6. Jonathan Basil Fitzgerald (9 out of 19 patents)
7. Thomas Joseph Wickham (9 out of 15 patents)
8. Dmitri B Kirpotin (8 out of 45 patents)
9. Daryl C Drummond (7 out of 36 patents)
10. Jeffrey David Kearns (7 out of 7 patents)
11. Victor Mandla Moyo (7 out of 43 patents)
12. Eric Krauland (6 out of 20 patents)
13. Brian Harms (6 out of 11 patents)
14. Raghida Bukhalid (6 out of 6 patents)
15. Bart S Hendriks (5 out of 7 patents)
52 patents:
4. 10184006 - Biomarkers for predicting outcomes of cancer therapy with ErbB3 inhibitors (2019-01-22),
6. 10072299 - Antibodies against epidermal growth factor receptor (EGFR) and uses thereof (2018-09-11),
12. 9902999 - Antibodies against epidermal growth factor receptor (EGFR) and uses thereof (2018-02-27),
Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines for the treatment of cancer. They are dedicated to advancing science and transforming patient care by targeting novel biological pathways. Merrimack Pharmaceuticals is committed to bringing hope to patients and improving their quality of life.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com